Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115344505 | 11534450 | 5 | F | 201506 | 20160711 | 20150922 | 20160715 | EXP | PHHY2015FR075430 | NOVARTIS | 58.00 | YR | M | Y | 85.00000 | KG | 20160716 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115344505 | 11534450 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | Y | 22334 | 10 | MG | QD | ||||||
| 115344505 | 11534450 | 2 | C | INEXIUM//ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 115344505 | 11534450 | 3 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | 2 MG, IF NEEDED | U | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115344505 | 11534450 | 1 | Metastatic renal cell carcinoma |
| 115344505 | 11534450 | 2 | Product used for unknown indication |
| 115344505 | 11534450 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115344505 | 11534450 | HO |
| 115344505 | 11534450 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115344505 | 11534450 | Cough | |
| 115344505 | 11534450 | Crepitations | |
| 115344505 | 11534450 | Dyslipidaemia | |
| 115344505 | 11534450 | Fatigue | |
| 115344505 | 11534450 | Glomerular filtration rate decreased | |
| 115344505 | 11534450 | Hepatocellular injury | |
| 115344505 | 11534450 | Malignant neoplasm progression | |
| 115344505 | 11534450 | Microalbuminuria | |
| 115344505 | 11534450 | Nail toxicity | |
| 115344505 | 11534450 | Pyrexia | |
| 115344505 | 11534450 | Rash | |
| 115344505 | 11534450 | Rash papular | |
| 115344505 | 11534450 | Type 2 diabetes mellitus | |
| 115344505 | 11534450 | Xerosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115344505 | 11534450 | 1 | 20150527 | 20160314 | 0 | |
| 115344505 | 11534450 | 2 | 20150527 | 0 |